Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Dapatab M 10mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Orris Pharmaceuticals

Salt Composition

Dapagliflozin (10mg) + Metformin (500mg)

Overview Dapatab M 10mg/500mg Tablet SR

Dapatab M 10mg/500mg Extended-Release Tablets combine two medications to manage type 2 diabetes. This treatment effectively lowers elevated blood glucose, mitigating the risk of severe diabetic complications and potentially cardiovascular events. Administer Dapatab M with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires medical consultation to avoid uncontrolled blood sugar, potentially leading to kidney impairment or vision loss. This medication complements a comprehensive diabetes management plan encompassing dietary adjustments, exercise, and weight control, as directed by your doctor. Commonly reported side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea). Adequate hydration is crucial to minimize dehydration. Genital fungal infections are a possibility; diligent hygiene can help. Prior to initiating treatment, disclose any kidney or liver issues, urinary tract infections, diuretic use, or pregnancy/breastfeeding to your physician. Limit alcohol consumption while on this medication to reduce potential side effects. Regular blood glucose monitoring is essential throughout treatment.

Primary Ingredients of Dapatab M 10mg/500mg Tablet SR

No text was provided to rewrite.

Uses of Dapatab M 10mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Dapatab M 10mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. Consume the Dapatab M 10mg/500mg sustained-release tablet with food.

Common Side effects of Dapatab M 10mg/500mg Tablet SR:

  • Nausea
  • Vomiting
  • Diarrhea
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Polyuria
  • Flatulence
  • Skin rash
  • Taste change
  • Difficulty in urination
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness
  • Back pain
  • Increased hematocrit
  • Decreased creatinine clearance
  • Dyslipidemia

How to use Dapatab M 10mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume the Dapatab M 10mg/500mg Sustained-Release tablet with food.

How Dapatab M 10mg/500mg Tablet SR works:

Dapatab M 10mg/500mg Extended-Release tablets combine dapagliflozin and metformin, two medications that manage blood sugar levels. Dapagliflozin facilitates glucose excretion via the urine, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Dapatab M 10mg/500mg SR tablets with alcohol is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dapatab M 10mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Dapitab M 10mg/500mg tablets are likely unsuitable for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Dapatab M 10mg/500mg SR tablets. Dosage modification of Dapatab M 10mg/500mg SR tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Dapatab M 10mg/500mg sustained-release tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Dapatab M 10mg/500mg Tablet SR :

Should you forget to take your Dapatab M 10mg/500mg SR Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dapatab M 10mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Dapatab M 10mg/500mg Tabl...
92
MRP 106
13% off